Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 2

Abstract

In current scenario of rising trend of resistant tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS) co infection with TB, a novel antitubercular drug is a prime need to effectively decrease the disease burden. In lieu of the fact that no new antitubercular drug has come up in last four decades, bedaquiline (TMC 207), an arylquinoline, seems an attractive option for TB patients because of its tendency to cause earlier and sustained antitubercular action, shorten treatment duration, less chances of resistance and better safety as compared to existing second line drugs. Bedaquiline has recently been approved by USFDA on 28th December, 2012 for treating multi drug resistant TB (MDR-TB) in adults ≥18 years. This review elucidates the available evidence on efficacy and safety of this drug after analyzing preclinical and clinical studies. Searches of pubmed, Cochrane database, Medscape, Google and clinicaltrial.org were made for terms like bedaquiline, TMC207 and MDR-TB.

Authors and Affiliations

Ruchika Nandha*| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India, Kamlesh Garg| Assistant Professor, Department of Clinical Research, Jamia Hamdard University, New Delhi, India, Harpal Singh| Consultant, Department of Critical Care, Max Superspeciality hospital, Phase 6, Mohali, India, Annu Maheshwari| Department of Pharmacology, Adesh Institute of Medical Sciences, Bathinda,India-Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India

Keywords

Related Articles

SEROFREQUENCY OF HEPATITIS D VIRUS AMONG HEPATITIS B INFECTED PATIENTS, KHARTOUM STATE, SUDAN.

Background: Hepatitis Delta virus (HDV) is a defective RNA virus dependent on Hepatitis B virus (HBV) infection for its replication and expression. It is estimated that approximately 5% of hepatitis B surface antigen (Hb...

The Comparsion of Piperacillin / Tazobactem with Clindamycin in Diabetic Foot Ulcers

To evaluate and compare the study and efficacy of piperacillin/tazobactem with clindamycin in diabetic foot ulcer according to Wagner’s different grades of classification of diabetic foot ulcer. The study was conducted...

STUDY OF PATTERNS OF PROPHYLACTIC ANTIBIOTIC USED IN SURGERICAL PROCEDURES IN TERTIARY CARE TEACHING HOSPITAL

Aim and Objective: This study was undertaken to evaluate the patterns of prescribing antibiotics for the purposeof prophylaxis in surgery to prevent post operational infection.Methodology: A retrospective analysis was pe...

OPTIMIZATION OF RHAMNOLIPID BIOSURFACTNT PRODUCTION BY STREPTOMYCES MATENSIS (NBRC 12889T) USING PLACKETT-BURMAN DESIGN

Surfactants produced by microorganisms are known as biosurfactants. Biosurfactants are becoming important biotechnology products for industrial and medical applications due to their specific modes of action, low toxicity...

DEVELOPMENT OF HPTLC FINGERPRINTS OF FLAVANOIDS USING QUERCETIN AND BAICALEIN AS MARKERS IN OROXYLUM INDICUM (L.) VENT

The study was aimed to develop the HPTLC fingerprints of Flavanoids using Quercetin and Baicalein as markers for leaf , stem and roots of the medicinally important plant Oroxylum indicum (L.) Vent collected from two diff...

Download PDF file
  • EP ID EP1646
  • DOI -
  • Views 397
  • Downloads 29

How To Cite

Ruchika Nandha*, Kamlesh Garg, Harpal Singh, Annu Maheshwari (2013). Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium. Journal of Biomedical and Pharmaceutical Research, 2(2), 15-20. https://europub.co.uk/articles/-A-1646